Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care, urology and surgery, will showcase its Arrow® GPSCath® Interventional Product Platform at the Leipzig Interventional Course (LINC) to be held in Leipzig, Germany on January 26 - 29, 2016.

During the event, Teleflex will highlight the Arrow® GPSCath® Balloon Dilatation Catheter, which features VisioValve™ Technology. The GPSCath® Catheter is a specialty two-in-one device that is indicated for percutaneous transluminal angioplasty (PTA) in the peripheral vasculature, including the iliac, femoral, popliteal, infrapopliteal and renal arteries.

Teleflex is pleased to present its Arrow® GPSCath® Catheter at three Satellite Symposiums during the event. The first presentation will be given by Dr. Marco Manzi from Policlinico Abano Terme, Italy and is entitled “Use of the Arrow® GPSCath® Catheter in a diabetic patient population with impaired renal function.” This presentation will be held at the Global Expert Exchange, Room 5, on Tuesday, January 26 at 15:24h.

The second presentation will be given by Prof. Marc Sapoval from Hôpital Européen Georges Pompidou, Paris, France and is entitled “Strategies in challenging BTK procedures: Arrow® GPSCath® Catheters with VisioValve™ Technology to protect wire placement, reduce fluoroscopy-time and minimize contrast media.” This presentation will be held on Thursday, January 28, at 11:00h, at Technical Forum, Room 3.

The third presentation is entitled “Contrast saving strategies for BTK recanalization with the Arrow® GPSCath® Catheter,” and will be given by Dr. Costantino Del Giudice from Hôpital Européen Georges Pompidou, Paris, France on Thursday, January 28, at 16:23h, at Main Arena 1, Room 1.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rüsch® and Weck® – trusted brands united by a common sense of purpose.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Teleflex, the Teleflex logo, Arrow, Deknatel, GPSCath, Hudson RCI, LMA, Pilling, Rusch, VisioValve and Weck are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. © 2016 Teleflex Incorporated. All rights reserved.

Teleflex IncorporatedJake ElguiczeTreasurer and Vice President, Investor Relations610-948-2836orMartina Teichmann-ZindlerDirector Marketing Communications International+49 (0)7151-406-538martina.teichmann@teleflex.com

Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Teleflex Charts.
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Teleflex Charts.